Showing results (471-480 of 495) with videos related to
Sort By:
Pageof 50
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.Influenza and Other Respiratory Viruses|October 16, 2023
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillanceSarah Denayer, François E Dufrasne, Bert Monsieurs, et al.ESMO Open|November 10, 2022
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the futureT Geukens, M Brandão, A Laenen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2024
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancerT Van Gorp, D Cibula, W Lv, et al.Prostate Cancer and Prostatic Diseases|May 10, 2017
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancerL Tosco, A Laenen, A Briganti, et al.Frontiers in Endocrinology|June 27, 2024
Impact of breastfeeding on risk of glucose intolerance in early postpartum after gestational diabetesYana Vanlaer, Caro Minschart, Hannah Vrolijk, et al.Neuron|November 29, 2022
Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patientsMona Khan, Marnick Clijsters, Sumin Choi, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2025
Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized studyIgnace Vergote, Larry J Copeland, Toon Van Gorp, et al.Nature Biotechnology|October 2, 2002
Arrayed adenoviral expression libraries for functional screeningFrits Michiels, Helmuth van Es, Luc van Rompaey, et al.Life (Basel, Switzerland)|February 25, 2022
Reliable and Scalable SARS-CoV-2 qPCR Testing at a High Sample Throughput: Lessons Learned from the Belgian InitiativeSteven Van Vooren, James Grayson, Marc Van Ranst, et al.Pageof 50